eng Science and Education Publishing American Journal of Medical Sciences and Medicine 2327-6657 2024-04-14 12 1 16 20 10.12691/ajmsm-12-1-2 AJMSM20241212 article Giuseppe Derosa giuseppe.derosa@unipv.it 1 2 Pamela Maffioli 2 Catherine Klersy 3 Virginia V. Ferretti 3 Angela D¡¯Angelo 3 3 Sergio Di Matteo 4 Giacomo M. Bruno 5 Giorgio L. Colombo 5 Centre of Diabetes and Metabolic Diseases, Department of Internal Medicine and Therapeutics, University of Pavia and IRCCS Policlinico San Matteo Foundation, Pavia, Italy Clinical Epidemiology and Biometrics Unit, IRCCS Policlinico San Matteo Foundation, Pavia, Italy S.A.V.E. Studi Analisi Valutazioni Economiche Research Centre, Milan, Italy Department of Drug Science, University of Pavia, Pavia, Italy It is well established that hypertension, hypercholesterolemia and type 2 diabetes (T2DM) are the main modifiable risk factors. The aim of this study was to identify the prevalence of dysglycemia in the general population screened during world diabetes day 2018 and 2019. In the context of the World Diabetes Day 2018 and 2019, promoted by the Department of Internal Medicine and Therapeutics, University of Pavia and IRCCS Policlinico San Matteo Foundation Hospital, Pavia, Italy, a total of 666 subjects aged ¡Ư 18 years, of either sex, agreed to participate in the screening for detection of pre-risk and risk cardiovascular factors. Exclusion criteria was prandial state. Participants included 274 men (41.14%) and 392 women (58.86%) with an average age of 55 (SD 13) years. There were 13 underweight subjects (1.95%), 317 subjects with normal weight (47.60%), 267 overweight subjects (40.09%) [body mass index (BMI), between 25.0 and 29.9 kg/m2] and 69 obese subjects (10.36%) (BMI ¡Ư 30 kg/m2). The prevalence of normo-glycemia was 61% (95% CI 57-65); of dysglycemia 28% (95% CI 24-31) and diabetes 11% (95% CI 9-14). In conclusions, in the context of the World Diabetes Day 2018 and 2019, we identified a prevalence of diabetes lower than the National reported value. Our main finding was the identification of a high prevalence of dysglycemic subjects, which should be taken into account in any primary or secondary prevention strategies. https://pubs.sciepub.com/ajmsm/12/1/2/ajmsm-12-1-2.pdf Dysglycemia dyslipidemia pre-hypertension hypertension pre-risk